Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05293808 Completed - Diabetes Mellitus Clinical Trials

Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin

DIABE-ASACS
Start date: May 1, 2014
Phase: Phase 4
Study type: Interventional

Diabetes is an important risk factor of coronary atherosclerosis, and it's well known that platelets of diabetic patients are hyper reactive and so resistant to common antithrombotic therapy. Moreover, in diabetic patients platelets are characterized by high turnover that is responsible of lack of protection by cardioaspirin at common dosage. The aim of our study is to asses the efficacy of different doses of aspirin in diabetic patients with acute coronary syndrome.

NCT ID: NCT05290493 Completed - Clinical trials for 22q11 Deletion Syndrome

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

Start date: February 10, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase 2, randomized, placebo-controlled crossover trial to assess the safety and efficacy of NB-001 in children and adolescents with 22q11DS that manifest commonly associated neuropsychiatric conditions.

NCT ID: NCT05290181 Completed - Clinical trials for Premenstrual Syndrome

The Effect of Pilates Exercise and Whatsapp Text-Based Support Program on Premenstrual Syndrome (PMS) Symptoms

PMS
Start date: January 12, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of Pilates exercise and Whatsapp text message-based support program on PMS symptoms experienced by university female students.

NCT ID: NCT05289531 Completed - Clinical trials for LARS - Low Anterior Resection Syndrome

(LARS) Score Validation of Turkish Language

Start date: February 1, 2016
Phase:
Study type: Observational [Patient Registry]

Long-term bowel dysfunction after resection for rectal cancer, known as low anterior resection syndrome (LARS), is observed in many patients. The LARS score was developed to measure this syndrome and its impact on quality of life in Danish patients. Recently, English and many other language versions have been validated. The aim of this study was to validate the Turkish translation of the LARS score in Turkish patients who have undergone treatment for rectal cancer.

NCT ID: NCT05283655 Completed - Clinical trials for Irritable Bowel Syndrome

Heart Rate Variability in Patients With Irritable Bowel Syndrome Before and After Gut-directed Hypnotherapy

Start date: December 7, 2016
Phase: N/A
Study type: Interventional

Dysregulation of the brain-gut-axis is believed to underlie symptom generation in irritable bowel syndrome (IBS). The Autonomous Nervous System (ANS) is an important route of brain-gut communication and aberrant ANS functioning, reflected in abnormalities in Heart Rate Variability (HRV) have been described in IBS. Gut-directed hypnotherapy (GHT) leads to symptom reductions in IBS and is supposed to increase parasympathetic regulation. To date, however, the role of therapeutic modulation of the ANS through GHT has been rarely examined. Aim of this pilot study is therefore to assess the impact of GHT on ANS functioning as reflected in heart rate variability. 24h-electrocardiogram before and after 10 sessions of gut-directed hypnotherapy will be administered in groups. Time and Frequency measures of Heart Rate Variability (HRV) will be extracted from 24h-electrocardiogram protocols as indicators of ANS regulation. Validated questionnaires will be utilized to assess IBS symptoms (IBS-SSS) and psychological distress (HADS-D).

NCT ID: NCT05282446 Completed - Metabolic Syndrome Clinical Trials

A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome

Start date: March 1, 2022
Phase: Phase 1
Study type: Interventional

INV-202-CL-105 is a phase 1B study to examine the safety and tolerability, as well as the pharmacokinetics (PK) pharmacodynamic (PD) effects of INV-202 in subjects with metabolic syndrome over 28 days.

NCT ID: NCT05280223 Completed - Clinical trials for Carpal Tunnel Syndrome

Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel Syndrome

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome (CTS) is a common peripheral entrapment neuropathy, this study aims to investigate if, and to what extent hydro-dissection hyalase and saline versus dexmedetomidine upon the median nerve could offer symptoms and clinical improvement

NCT ID: NCT05277428 Completed - Clinical trials for Irritable Bowel Syndrome With Diarrhea

Clinical Study to Evaluate the IBS Symptoms Improving Effect and Safety of GTB1

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

This study was conducted to investigate the effects of daily supplementation of L. plantarum APsulloc 331261(GTB1TM) on improvement of IBS symptoms.

NCT ID: NCT05271201 Completed - Down Syndrome Clinical Trials

Exercise Intensity for Down Syndrome Children

Start date: December 10, 2019
Phase: N/A
Study type: Interventional

The current study aimed to determine the appropriate exercise intensity for the rehabilitation of children with down syndrome.

NCT ID: NCT05271071 Completed - Piriformis Syndrome Clinical Trials

The Importance of Gluteus Maximus Muscle in Patients With Preliminary Diagnosis of Piriformis Syndrome

Start date: March 14, 2022
Phase: N/A
Study type: Interventional

Literature shows different pathologies or combination pathologies can cause gluteal region pain and it can be difficult to diagnose. Piriformis syndrome is one of the cause of gluteal region pain, symptoms of myofascial pain syndrome affected gluteus maximus muscle may masquerade as piriformis muscle syndrome or both syndrome can be seen together. The aim of this study is diagnosis myofascial pain syndrome of gluteus maximus muscle and piriformis syndrome by physical examination, special clinical tests and ultrasound guided diagnostic injection test in patients presenting with gluteal pain and evaluate the coexistence of both syndromes.